Science Machine · PCOS, audited

Which outcomes PCOS trials report

A count of 576 randomised PCOS treatment trials published 2016 to 2026, and which outcomes each one reports.

Quality of life or satisfaction

10.6%

of 576 trials report quality of life or treatment satisfaction (95% interval 8.3 to 13.4). experiments/outcome_audit/LINKAGE_RESULTS.md:52-53

This is the cleanest number on the page. Quality of life and satisfaction are two of the outcomes the 2020 PCOS core outcome set recommends every trial report, so the definition comes from outside this project. experiments/outcome_audit/CROSS_CONDITION_RESULTS.md:169,179-180 "Reported" means the trial's paper gives a result for it or clearly states it was assessed. A trial can collect an outcome and never report it; we can only count what is in print.

Outcomes on our patient-centred list

Our patient-centred list is: quality of life, treatment satisfaction, depression, anxiety, eating disorders, diabetes as a diagnosis, live birth, and patient-reported symptom scores. experiments/outcome_audit/RESULTS.md:23-25 How many trials report "any of them" depends on what goes on the list, so we give the range rather than one number.

DefinitionTrials reporting at least one
List without live birth and diabetes15.7%
List as registered22.2% (19.0 to 25.8)
List plus periods, hair and acne45.0%
576 trials. experiments/outcome_audit/PUBLISH_FIRST_PLAN.md:46-48 experiments/outcome_audit/LINKAGE_RESULTS.md:57 docs/REVIEW_PMOS_AUDIT_2026-10-26.md:136 palace/threads/outcome-audit-pmos.md:38

The range is the honest finding: the answer depends on the definition. Periods, hair and acne are symptoms women live with, but they were not on the registered list.

What trials report most, and least

From the first reading, 412 published trial reports in the audit sample. experiments/outcome_audit/RESULTS.md:40-62

OutcomeShare reporting it
Hormone levels54%
Glucose and insulin47%
BMI45%
Androgens (blood)41%
Periods22%
Hair growth16%
Acne8%
Quality of life6.6%
Depression6.6%
Anxiety6.1%
Treatment satisfaction2.7%
Diabetes as a diagnosis0.5% (2 trials)
Paper-level first reading. experiments/outcome_audit/RESULTS.md:41-59

Most trials last about 12 weeks, which is too short for diabetes to be diagnosed. The low diabetes figure says as much about trial length as about reporting. experiments/outcome_audit/RESULTS.md:15-16

Over time

This comparison was chosen after the first results were seen.

Publication yearsQuality of life or satisfaction
2016 to 20196.8% (4.1 to 11.1)
2020 to 202210.2% (6.5 to 15.7)
2023 to 202614.7% (10.5 to 20.2)
Trial level, all 576 trials. experiments/outcome_audit/LINKAGE_RESULTS.md:54-56

Why these are lower bounds

Retractions and notices

A later check of the 602 eligible papers against PubMed found 17 with a linked retraction, 22 with a linked expression of concern and 14 with a linked erratum. experiments/source_check/outcome-audit/SOURCE_CHECK.md:3,13-15

The figures above still include these papers. A rule for handling them will be written down before the numbers are recomputed.

How it was read

Each trial report was coded against a fixed codebook by an AI reader. A second reading of a sample used the same model again experiments/outcome_audit/PUBLISH_FIRST_PLAN.md:53, so agreement between those two readings measures consistency, not accuracy. The independent check is the re-reading by models from two other vendors, described in the box above. The plan was committed before any reading began. experiments/outcome_audit/RESULTS.md:18